Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance

International Immunopharmacology

Volumn 8, Issue 2, 2008, Pages 330-340

  Chakraborty, Krishnendu ^a   Bose, Anamika ^a   Pal, Smarajit ^b   Sarkar, Koustav ^a   Goswami, Shyamal ^a   Ghosh, Diptendu ^a   Laskar, Subrata ^d   Chattopadhyay, Utpala ^c   Baral, Rathindranath ^a  

^a Department of Immunoregulation and Immunodiagnostics ^*  (India)

^b CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^c UNIVERSITY OF CALCUTTA   (India)

^d UNIVERSITY OF BURDWAN   (India)

Author keywords

Chemotaxis; CXCL10; CXCR3; Cytotoxicity; IFN ; Neem leaf glycoprotein

Indexed keywords

AZADIRACHTA INDICA EXTRACT; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG CYTOTOXICITY; FLOW CYTOMETRY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOMODULATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; SWISS WEBSTER MOUSE;

ADULT; ANIMALS; AZADIRACHTA; CARCINOMA, SQUAMOUS CELL; CHEMOKINE CXCL10; CHEMOTAXIS, LEUKOCYTE; FEMALE; GLYCOPROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MIDDLE AGED; PLANT LEAVES; RECEPTORS, CXCR3; SIGNAL TRANSDUCTION;

EID: 37649007427     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.10.015     Document Type: Article

References (35)

1. Biswas K., Chattopadhyay I., Banerjee R.K., and Bandopadhyay U. Biological activities and medicinal properties of neem (Azadirachta indica). Curr Sci 82 (2002) 1336-1345
2. Haque E., Mandal I., Pal S., and Baral R. Prophylactic dose of neem (Azadirachta indica) leaf preparation restricting murine tumor growth is nontoxic, hematostimulatory and immunostimulatory. Immunopharmacol Immunotoxicol 28 (2006) 33-50
3. Baral R.N., Mandal I., and Chattopadhyay U. Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine. Int Immunopharmacol 5 (2005) 1343-1352
4. Haque E., and Baral R.N. Neem (Azadirachta indica) leaf preparation induces prophylactic growth inhibition of murine Ehrlich carcinoma in Swiss and C57BL/6 by activation of NK cells and NK-T cells. Immunobiology 21 (2006) 721-731
5. Mandal-Ghosh I., Chattopadhyay U., and Baral R. Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen. Cancer Immun 7 (2007) 8-17
6. Ghosh D., Bose A., Haque E., and Baral R.N. Pretreatment with neem (Azadirachta indica) leaf preparation in Swiss mice diminishes leukopenia and enhances anti-tumor activity of cyclophosphamide. Phytother Res 20 (2006) 814-818
7. Sarkar K., Bose A., Laskar S., Choudhuri S.K., Dey S., Roychowdhury P.K., et al. Antibody response against neem leaf preparation recognizes carcinoembryonic antigen. Int Immunopharmacol 7 (2007) 306-312
8. Bose A., Ghosh D., Pal S., Chaudhuri S., and Baral R.N. Neem leaf preparation enhances in vitro cytotoxic efficacy of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients. Indian J Med Res 121 (2005) 60
9. Upadhyay S.N., Dhawan S., Garg S., and Talwar G.P. Immunomodulatory effects of neem (Azadirachta indica) oil. Int Immunopharmacol 14 (1992) 1187-1193
10. Kagi D., Ledermann E., Burki K., Zinkernagel R.M., and Hengartner. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 14 (1996) 207-232
11. Baral R.N., Chakraborty A., and Maity P. Alterations in large gut associated lymphatic tissues (LGALT) during experimental colorectal carcinogenesis. Indian J Exp Biol 31 (1993) 793-796
12. Wada Y., Nakashima O., Kutami R., Yamamoto O., and Kojiro M. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 27 (1998) 407-414
13. Ng I.O., Lai E.C., Fan S.T., Ng M.M., and So M.K. Prognostics significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients. Cancer 76 (1995) 2443-2448
14. Liu Y.Q., Poon R.T., Hughes J., Li Q.Y., Yu W.C., and Fan S.T. Desensitization of T lymphocytes function by CXCR3 ligands in human hepatocellular carcinoma. World J Gastroenterol 11 (2005) 164-170
15. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6 (2006) 295-307
16. Moser B., and Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2 (2001) 123-128
17. Gale L.M., and McColl S.R. Chemokines: extracellular messengers for all occasions?. BioEssays 21 (1999) 17-28
18. Baral R.N., and Chattopadhyay U. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma. Int Immunopharmacol 4 (2004) 355-366
19. Dubois M., Gilles K.A., Hamilton J.K., Rubers P., and Smith F. Colorometric method for determination of sugars and related substances. Anal Chem 28 (1956) 350-356
20. Ohtani H. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immunol 7 (2007) 8-17
21. Nakano O., Sato M., Naito Y., Suzuki K., Orikasa S., Suzuki Y., et al. Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 61 (2001) 5132-5136
22. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301-314
23. Goldberg-Bittman I., Neumark E., Sagi-assif O., Azenshtein E., Meshel T., Witz I.P., et al. The expression of chemokine receptor CXCR3 and its ligand CXCL10, in human breast adenocarcinoma cell lines. Immunol Lett 92 (2004) 171-178
24. Feferman T., Maiti P.K., Berrih-Aknin S., Bismuth J., Bidault J., Fuchs S., et al. Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis. J Immunol 174 (2005) 5324-5331
25. Dutta D., Flaxenburg J.A., Laxmanan S., Geehan C., Grimm M., Waaga-Gasser A.M., et al. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: Relevance for the development of human breast cancer. Cancer Res 66 (2006) 9509-9518
26. Baggiolini M. Chemokines and leukocyte traffic. Nature 392 (1998) 565-568
27. Romagnani P., Lasagni L., Annunziato F., Serio M., and Romagnani S. CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol 25 (2004) 201-209
28. Strieter R.M., Belperio J.A., Burdick M.D., and Keane M.P. CXC chemokines in angiogenesis relevant to chronic fibroproliferation. Curr Drug Targets Inflamm Allergy 4 (2005) 23-26
29. Glaser J., Gonzalez R., Perreau V.M., Cotman C.W., and Keirstead H.S. Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury. J Neurosci Res 77 (2004) 701-708
30. Kelsen S.G., Aksoy M.O., Yang Y., Shahabuddin S., Litvin J., Safadi F., et al. The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 287 (2004) L584-L591
31. Bose A., and Baral R.N. NK cellular cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L mediated endogenous production of IL-12. Human Immunol 68 (2007) 823-831
32. Vollmer J., Jurk M., Samulowitz U., Lipford G., Forsbach A., Wullner M., et al. CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells. J Endotoxin Res 10 (2004) 431-438
33. Padovan E., Spagnoli G.C., Ferrantini M., and Heberer M. IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+effector T cells. J Leukoc Biol 71 (2002) 669-676
34. Singh U.P., Singh S., Iqbal N., Weaver C.T., McGhee Jr. C.T., and Lillard Jr. J.W. IFN-gamma-inducible chemokines enhance adaptive immunity and colitis. J Interferon Cytokine Res 23 (2003) 591-600
35. Okamoto M., Kawabe T., Iwasaki Y., Hara T., Hashimoto N., Imaizumi K., et al. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions. J Lab Clin Med 145 (2005) 88-93